Indoxyl Sulfate Is a Nephro-Vascular Toxin

Journal of Renal Nutrition

Volumn 20, Issue 5, 2010, Pages S2-S6

  Niwa, Toshimitsu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010134     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.05.002     Document Type: Article

References (47)

1. Niwa, T., Uremic toxicity, indoxyl sulfate. Massry, S.G., Glassock, R.J., (eds.) Textbook of Nephrology, 2001, Lippincott Williams & Wilkins, Philadelphia, PA, 1269–1272.
2. Niwa, T., Ise, M., Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 124 (1994), 96–104.
3. Niwa, T., Ise, M., Miyazaki, T., Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 14 (1994), 207–212.
4. Miyazaki, T., Ise, M., Seo, H., et al. Indoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and proα1(I) collagen in kidneys of uremic rats. Kidney Int 52:Suppl 62 (1997), S15–S22.
5. Niwa, T., Yazawa, T., Ise, M., et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 57 (1991), 84–88.
6. Niwa, T., Emoto, Y., Maeda, K., et al. Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients. Nephrol Dial Transplant 6 (1991), 105–109.
7. Niwa, T., Miyazaki, T., Hashimoto, N., et al. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats. Am J Nephrol 12 (1992), 201–206.
8. Niwa, T., Miyazaki, T., Tsukushi, S., et al. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis. Nephron 74 (1996), 72–78.
9. Niwa, T., Tsukushi, S., Ise, M., et al. Indoxyl sulfate and progression of renal failure: effects of low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrol Metab 23 (1997), 179–184.
10. Niwa, T., Nomura, T., Sugiyama, S., et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 52:Suppl 62 (1997), S23–S28.
11. Miyazaki, T., Aoyama, I., Ise, M., et al. An oral sorbent reduces overload of indoxyl sulfate and gene expression of TGF- β1 in uremic rat kidneys. Nephrol Dial Transplant 15 (2000), 1773–1781.
12. Niwa, T., Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 16 (1996), 167–182.
13. Niwa, T., Aoyama, I., Takayama, F., et al. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure. Miner Electrol Metab 25 (1999), 118–122.
14. Miyazaki, T., Ise, M., Hirata, M., et al. Indoxyl sulfate stimulates renal synthesis of transforming growth factor-β1and progression of renal failure. Kidney Int 52:Suppl 63 (1997), S211–S214.
15. 1 expression in hypercholesterolemic rats. Kidney Int 56:Suppl 71 (1999), S193–S197.
16. Aoyama, I., Miyazaki, T., Niwa, T., Preventive effects of an oral sorbent on nephropathy in rats. Miner Electrol Metab 5 (1999), 365–372.
17. Aoyama, I., Shimokata, K., Niwa, T., Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-β1 expression in spontaneously diabetic (OLETF) rats. Am J Nephrol 20 (2000), 232–241.
18. Aoyama, I., Niwa, T., Molecular insights into preventive effect of AST-120 on the progression of renal failure. Clin Exp Nephrol 5 (2001), 209–216.
19. Aoyama, I., Niwa, T., An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Am J Kidney Dis 37:Suppl 2 (2001), S7–S12.
20. Aoyama, I., Shimokata, K., Niwa, T., Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats. Nephron 90 (2002), 297–312.
21. Aoyama, I., Shimokata, K., Niwa, T., An oral adsorbent down-regulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 92 (2002), 635–651.
22. Aoyama, I., Enomoto, A., Niwa, T., Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis. Am J Kidney Dis 41:Suppl 1 (2003), S8–S14.
23. Schulman, G., Agarwal, R., Acharya, M., et al. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 47 (2006), 565–577.
24. Iida, S., Kohno, K., Yoshimura, J., et al. Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure. Clin Exp Nephrol 10 (2006), 262–267.
25. Konishi, K., Nakano, S., Tsuda, S., et al. AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects. Diabetes Res Clin Pract 81 (2008), 310–315.
26. Motojima, M., Hosokawa, A., Yamato, H., et al. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int 63 (2003), 1671–1680.
27. Gelasco, A.K., Raymond, J.R., Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 290 (2006), F1551–F1558.
28. Owada, S., Goto, S., Bannai, K., et al. Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats. Am J Nephrol 28 (2008), 446–454.
29. Taki, K., Niwa, T., Indoxyl sulfate-lowering capacity of oral sorbents affects prognosis of kidney function and oxidative stress in chronic kidney disease. J Ren Nutr 17 (2007), 48–52.
30. Tumur, Z., Niwa, T., An oral sorbent AST-120 increases renal NO synthesis in uremic rats. J Ren Nutr 18 (2008), 60–64.
31. Enomoto, A., Takeda, M., Tojo, A., et al. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 13 (2002), 1711–1720.
32. Enomoto, A., Takeda, M., Taki, K., et al. Interactions of human organic anion as well as cation transporters with indoxyl sulfate. Eur J Pharmacol 466 (2003), 13–20.
33. Taki, K., Nakamura, S., Miglinas, M., et al. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure. J Ren Nutr 16 (2006), 199–203.
34. Dou, L., Bertrand, E., Cerini, C., et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65 (2004), 442–451.
35. Yamamoto, H., Tsuruoka, S., Ioka, T., et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69 (2006), 1780–1785.
36. Muteliefu, G., Enomoto, A., Niwa, T., Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress. J Ren Nutr 19 (2009), 29–32.
37. Taki, K., Tsuruta, Y., Niwa, T., Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. Am J Nephrol 27 (2007), 30–35.
38. Adijiang, A., Goto, S., Uramoto, S., et al. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 23 (2008), 1892–1901.
39. Muteliefu, G., Enomoto, A., Jiang, P., et al. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant 24 (2009), 2051–2058.
40. Tumur, Z., Niwa, T., Indoxyl sulfate inhibits NO production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol 29 (2009), 551–557.
41. Shimoishi, K., Anraku, M., Kitamura, K., An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharm Res 24 (2007), 1283–1289.
42. Namikoshi, T., Tomita, N., Satoh, M., et al. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Hypertens Res 32 (2009), 194–200.
43. Nakamura, T., Kawagoe, Y., Matsuda, T., et al. Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure. Kidney Blood Press Res 27 (2004), 121–126.
44. Barreto, F.C., Barreto, D.V., Liabeuf, S., et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4 (2009), 1551–1558.
45. Nii-Kono, T., Iwasaki, Y., Uchida, M., et al. Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71 (2007), 738–743.
46. Iwasaki, Y., Yamato, H., Nii-Kono, T., et al. Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Nephrol Dial Transplant 21 (2006), 2768–2774.
47. Niwa, T., Uremic toxicity of indoxyl sulfate. Nagoya J Med Sci 72 (2010), 1–11.